Lithuania to Ban Flavored E-Cigarettes Starting November 2024

Oct.08.2024
Lithuania to Ban Flavored E-Cigarettes Starting November 2024
Lithuania to ban flavored e-cigarettes from November 2024, aiming to protect public health, especially young people, from harmful effects.

According to a report from Lrt on October 3rd, starting in November 2024, Lithuania will no longer allow e-cigarettes that contain added or natural sweeteners and liquid sugars.


Rytis Jokubauskas, Vice President of the Consumer Alliance, pointed out that banning flavored e-cigarettes, related e-liquids, and supplements is an important measure to protect public health, especially the young population that needs protection. The marketing of e-cigarettes often targets young people, and consumers often lack comprehensive and objective information about the consequences of using e-cigarettes. The ban helps to create a safer environment and reduce the occurrence of public health problems.


In Lithuania's official government-run e-cigarette stores, despite the ban on flavored tobacco, only the names have been removed from product packaging. Consumers can still obtain detailed information about e-cigarette flavors when they inquire. According to the State Consumer Rights Protection Authority (VVTAT), this dishonest practice makes regulatory work more difficult, as samples need to be sent to laboratories for testing. However, the majority of test results have shown that the samples contain prohibited substances.


Since the ban on selling e-cigarettes and e-cigarette liquids with flavors and scents (excluding tobacco flavor) went into effect on July 1, 2022, VVTAT has reviewed 23 cases and decided to impose fines ranging from €750 to €2000 on violators. Most of the decisions have been appealed to the courts, but some companies have already paid the fines. Currently, only a few first-instance courts have ruled that VVTAT's decisions are reasonable, and these rulings are still being appealed to higher courts. A representative of VVTAT stated that this information has been transmitted to the National Drug, Tobacco, and Alcohol Control Department (NTAKD), which has the authority to suspend or revoke sales licenses for tobacco products.


The VVTAT revealed that regulating laws require a significant amount of manpower and financial resources, including inspections, sample collection and testing at physical stores, and legal procedures. These costs are covered by the state budget, which is funded by the contributions of every Lithuanian citizen. The leaders of the National Tobacco Manufacturers Association (NTGA) and the Innovation Tobacco Products Association have noticed a lack of market supervision and are calling for the promotion of trust among sellers.


According to VVTAT, with the amendments to the Tobacco, Tobacco Products and Related Products Management Act taking effect on November 1, 2023, it is expected that regulations will become clearer and simpler, thus improving the implementation of legal oversight.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Kenya’s BAT Kenya resumes Velo nicotine pouches after citing regulatory clarity
Kenya’s BAT Kenya resumes Velo nicotine pouches after citing regulatory clarity
BAT Kenya says it has resumed sales of Velo oral nicotine pouches after receiving regulatory clarity, reinforcing its push into non-combustible products as cigarette consumption falls.The company reported a 10% drop in turnover in 2025, with revenue closing at KSh23.2 billion (about $178.64 million), largely attributed to the growing presence of illegal tobacco products.
Mar.03 by 2FIRSTS.ai
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Exclusive | Shenzhen Tobacco Authorities Ask Licensed Chinese Vape Manufacturers to Submit STN Details for U.S.-Bound Products
Shenzhen tobacco authorities have asked licensed Chinese vape manufacturers to submit STN details for U.S.-bound products, including CTP Portal or STN email screenshots, highlighting a new compliance signal in cross-border oversight.
Apr.02
Product | GEEKBAR Expands High-Puff Lineup; CLR 50K and Clio X Highlight Displays and Transparent E-Liquid Tanks
Product | GEEKBAR Expands High-Puff Lineup; CLR 50K and Clio X Highlight Displays and Transparent E-Liquid Tanks
GEEKBAR has added two new vaping products on its official website. Both feature transparent e-liquid tanks and are rated for up to 50,000 puffs. The CLR 50K is equipped with a 17 ml e-liquid capacity, is labeled at 5% nicotine (50 mg/ml), and offers Normal and Pulse modes, while the Clio X carries a 16 ml capacity, a dual-screen display, and three output modes.
Feb.28 by 2FIRSTS.ai
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
VCU Signs Letter of Intent to Buy Altria Building for USD 150 Million, Pending State Approval
Virginia Commonwealth University has signed a letter of intent to acquire Altria Group’s 450,000-square-foot building in downtown Richmond for USD 150 million, but the deal still depends on approval from the General Assembly. The university said the facility would support expansion of the Massey Comprehensive Cancer Center and help grow enrollment in its new School of Public Health and School of Pharmacy. VCU also said constructing a comparable facility would cost about USD 715 million.
Mar.13 by 2FIRSTS.ai
Philippine DTI Says Flavored Vape Products With Minor-Appealing Descriptors Are “100 Percent Smuggled”
Philippine DTI Says Flavored Vape Products With Minor-Appealing Descriptors Are “100 Percent Smuggled”
A Philippine Department of Trade and Industry official told a Senate hearing on vaping regulations that flavored vape products marketed with descriptors attractive to minors are “100 percent smuggled” and did not pass the agency’s licensing process.
Mar.16 by 2FIRSTS.ai
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
PMTA Roundtable Opens with Industry Questioning Product Characterization Standards, FDA Defends Regulatory Boundaries
At the opening of FDA’s PMTA roundtable, small ENDS manufacturers warned that unclear product characterization standards are limiting their ability to invest and raise capital. FDA officials acknowledged industry concerns but said regulatory flexibility is constrained by statutory and procedural boundaries.
Feb.11